However, lubiprostone has been reported to activate the EP1 and EP4 receptors [29], while a previous study reported that an EP2 receptor agonist inhibited diclofenac-induced cytokine stimulation in nasal polyp cells [30]. Here, PTGER1 is linked to nasal cavity polyp.